Levels of BECN1 mRNA expression have been reported to be reduced in breast cancer (Li et al., 2010, Wu et al., 2012b) and have been associated with poor differentiation, and increased tumor size, proliferation and risk of metastasis (Wu et al., 2012b, Yao et al., 2011). The gene discussed is BECN1; the disease is breast cancer.